Beijing 2022: Valieva's 'B' sample yet to be examined

The B-sample of Russian figure skater Kamila Valieva's drug test before the Beijing Olympics is yet to be analysed despite an initial positive result, the International Olympic Committee said.

The teenager was cleared to compete in Tuesday single event after a Court of Arbitration for Sport (CAS) ruling that agreed with the Russian Anti-Doping Agency's (RUSADA) decision to lift a ban on her.

Valieva, 15, was tested at her national championships on 25 December, but the positive test for a banned angina drug was not revealed until 8 February, after she had already competed at the Beijing Games.

CAS's decision to let Valieva compete, on the grounds that maintaining the suspension would cause her irreparable damage, has prompted outrage from athletes and officials around the world.

If Valieva finishes in the top three of the women's single event, the medal ceremony will not be held during the Winter Games.

The 7 February medal ceremony for the women's team event, in which the USA, Japan and Canada finished after the Russian Olympic Committee, also cannot go ahead.

Denis Oswald, the permanent chair of the IOC's disciplinary commission, said the ceremony delay was necessary because the drug case was not resolved.

"We want to allocate the medal to the right person," Oswald told a press conference. He also claimed that that a "15-year-old would not do something wrong alone."

On Monday, in an interview with Reuters. World Anti-Doping Agency (WADA) president Witold Banka called for a life ban on those who would dope a minor.

Oswald said that given the B sample had not yet been examined by the laboratory, any ban would only be decided once there was a final decision on the case.

Valieva, who is due to compete at the single competition, spoke